PLENARY
SPEAKERS
Prof Kim Donaghue
Prof Donaghue remains research active at the University of Sydney, having recently retired from clinical practice at the Children’s Hospital at Westmead (CHW), where she had been Head of the Diabetes Complications Assessment Service, Head of Diabetes Services and CoHead of Endocrinology. She has published over 220 peer reviewed manuscripts and book chapters. Her major research focus has been the pathogenesis of and intervention for diabetes complications. She serves on the Steering Committee for the FAME-1 Eye Trial, an international interventional trial to reduce eye complications.
She currently leads a data linkage project on adult outcomes of childhood-onset
diabetes and cosupervises outcomes and data linkage with the Australasian
Diabetes Database Network (ADDN) registry. She was awarded the 2015 Australasian Paediatric Endocrine Group (now ANZSPED) Norman Wettenhall Award for Research and Innovation, the 2022 International Society for Pediatric and Adolescent Diabetes (ISPAD) Prize of Achievement and an Australian Diabetes Society Lifetime Achievement Award in 2022.
Dr Donaghue was APEG (now ANZSPED) President 2001-3 serving as Councillor, Treasurer, President and Vice President (1997-2005) and Inaugural Chair of Education Committee (2006-2010). She served on the Royal Australasian College of Physicians Specialty Advisory Committee in Endocrinology. She has given invited lectures for APPES in 1998 and 2010; and invited lectures for the American Diabetes Association, IDF, ESPE, ATTD, ISPE, IMPE. Dr Donaghue was ISPAD President 2018-2020 and led the ISPAD Clinical Practice Consensus Guideline “Vascular complications of diabetes” from 2000 to 2018. She was a recent consultant in diabetes for the World Health Organization and authored the successful submission for WHO EML listing of insulin pen devices in 2023.
In 2025 she was elected to the International Diabetes Federation (IDF) Executive Board as Vice President Strategic Governance. She has 217 Scopus listed papers, and been cited 13,622 times with an H-index of 56.
Prof Kim Donaghue
Australia
Prof Olaf Hiort
Professor Olaf Hiort is a full Professor of Paediatrics at the University of Lübeck in Germany. He studied Economics at the University of Hamburg and Human Medicine at the University of Hamburg and at Tufts University of Medicine in Boston, graduating in 1989. He trained in Paediatrics with subspecialities neonatology, paediatric endocrinology and diabetes, as well as laboratory medicine in paediatrics. He obtained his M.D., Ph.D. in 1999 and became Professor in 2001 at the University of Lübeck, currently heading the Division of Paediatric Endocrinology and Diabetes. His scientific focus is on rare endocrine conditions of sex development and calcium and phosphate metabolism. He has coordinated several European projects regarding rare endocrine conditions, namely EuroDSD funded under the 7th EU framework programme and DSDnet, funded as a COST Action under Horizon 2020.
Currently he serves as deputy coordinator and paediatric chair of the European Reference Network for Rare Endocrine Conditions (Endo-ERN). He led the establishment of quality-controlled centres for the care of people with variants of sex characteristics in Germany (DSDCare) and is currently the speaker of the Collaborative Research Centre “sexdiversity - determinants, meanings, and implications of sex diversity in sociocultural, medical and biological landscapes”, funded by the German Research Foundation, which connects 65 scientists mainly from the University of Lübeck dedicated to study the diversity of biological sex.
Prof Olaf Hiort
Germany
A/Prof Albert Wiegman
Albert Wiegman, Amsterdam, became a paediatrician and member of the staff at the Amsterdam University Medical Centres in 1991. In 1993, he completed his sub-specialization in paediatric cardiology, and the Paediatric-Lipid Department came under his care. He started the detection and treatment of children with homozygous and heterozygous familial hypercholesterolemia and other dyslipidaemias in the Netherlands. In 2020, he was appointed Associate Professor and Principal Investigator.
In 30 years, over 4000 children with inherited dyslipidaemias visited his ward. He co-authored more than 150 peer-reviewed papers in this field. Since 2024, he is an appointed trustee of the Familial Hyperlipidaemia Europe Foundation and a core group member of the Lipoprotein(a) International Taskforce.
A/Prof Albert Wiegman
The Netherlands
SYMPOSIA & MANAGEMENT SESSION SPEAKERS
Speakers are listed in alphabetical order of surname. Click on the speakers picture to see their biography and when they are presenting.
- ALL SPEAKERS
Dr Kate Armstrong
Kate Armstrong (B Med, DCH, MPH, FAFPHM, DrPH) works as a Public Health Physician in Australia and is a Fellow of the Australasian Faculty of Public Health Medicine.
Kate is Founder and President of CLAN (Caring & Living As Neighbours - www.clanchildhealth.org), an Australian NGO committed to equity for children living with non-communicable diseases (NCDs) and other chronic health conditions in lower income settings. CLAN is in special consultative status with ECOSOC and a proud member of the WHO/GCM on NCDs and WHO Civil Society Commission. Kate is Immediate Past Co-Chair of the International Pediatric Association’s Working Group on Access to Essential Medicines, Diagnostics and Equipment, and a member of the WHO/GCM NCD Lab Steering Committee.
In 2010 Kate chaired international advocacy efforts to promote the voices and perspectives of children and adolescents within the global non-communicable disease (NCD) discourse, serving as founding Chair of NCD Child (www.ncdchild.org).
Kate’s DrPH delivered a health needs assessment to understand and redress inequities facing children and young people living with Nephrotic Syndrome in Vietnam. More recently Kate has been facilitating efforts of Civil Society as Co-Chair of @MATES4Kids (Maximising Access To Essential Supplies for Children – www.mates4kids.org), a coalition committed to reducing the preventable mortality associated with one particular childhood NCD (Congenital Adrenal Hyperplasia) by 30% by 2030.
Speaker Presentation
Dr Ahila Ayyavoo
Dr Ahila Ayyavoo, DCH, DNB (Paed), PhD, is a Consultant in Paediatric Endocrinology and Diabetes at G. Kuppuswamy Naidu Memorial Hospital & Masonic Medical Centre for Children, Coimbatore. She is the Past President of the Indian Society for Pediatric & Adolescent Endocrinology (ISPAE) (2023–24), and has previously served as Secretary and Treasurer. Dr Ayyavoo is an Executive Council Member of APPES (2025–26) and is actively involved with the Rotary Club Smart City, Coimbatore, supporting children with type 1 diabetes through access to insulin, glucose monitoring supplies, and livelihood assistance for families. Her clinical and research interests focus on developing simple, practical solutions for complex endocrine disorders in the Indian context. She has held key organisational roles in multiple ISPAE scientific meetings and Fellow Schools, received the John Funder Prize for best PhD research publication in 2013, and is a recognised PhD guide in Paediatric Endocrinology and Diabetes. Dr Ayyavoo has received international research grants and has published widely in leading national and international journals.
Speaker Presentation
A/Prof Nicholas Beng Hui Ng
Associate Professor Nicholas Ng is a Consultant Paediatric Endocrinologist at the National University Hospital (NUH), Singapore and an adjunct associate professor at the Department of Paediatrics at the National University of Singapore (NUS). His clinical and research interests include growth, diabetes, obesity, and obesity-related complications. He has authored more than 50 peer-reviewed publications in these fields.
He serves on the European Society of Paediatric Endocrinology (ESPE) Obesity Workgroup and is actively involved in developing the international paediatric obesity guidelines, where he is the
section lead for treatment strategies for paediatric obesity. He is also a member of the International Paediatric Metabolic dysfunction Associated Steatotic Liver Disease (MASLD) consensus workgroup and the Polycystic Ovary Syndrome Global Name Change Consortium. A/Prof Ng is a passionate educator and is currently the Program Director of the NUHS Paediatric Residency Programme in Singapore. Within the Asia Pacific Paediatric Endocrine Society (APPES), he serves on the Education, Learning and Fellows (ELF) Subcommittee.
Speaker Presentation
Dr Alison Boyce
Dr. Boyce completed her pediatric endocrinology fellowship training in the NICHD Program on Developmental Endocrinology and Genetics, and her pediatric residency and medical training at Eastern Virginia Medical School in Norfolk, Virginia. She has held current and previous faculty positions in the NIH Pediatric Endocrinology fellowship training program and Children’s National Hospital. She is active in the patient advocacy community and serves as a Medical Advisor to the FD/MAS Alliance.
ISCBH sponsored speaker
Speaker Presentation
Professor Louise Burke
Louise is a sports dietitian with 45 years of experience in the education and counselling of elite athletes. She worked at the Australian Institute of Sport for thirty years, first as Head of Sports Nutrition and then as Chief of Nutrition Strategy. She has attended 6
Summer Olympic Games with the Australian Olympic Team (1996-2012 and 2021). Her publications include over 450 peer-reviewed papers and book chapters, and the authorship or editorship of several textbooks on sports nutrition.
Louise was a founding member of the Executive of Sports Dietitians Australia and is a Director of the IOC Diploma in Sports Nutrition. She was awarded a Medal of the Order of Australia in 2009 for her contribution to sports nutrition, and a Doctor of Science (Honoris causa) from McMaster University, Canada in 2024. Louise was appointed as Chair in Sports Nutrition in the Mary MacKillop Institute of Health Research at Australian
Catholic University in Melbourne in 2014 and took up this position in a full-time capacity in 2020.
Speaker Presentation
Dr Yoon Hi Cho
Dr Yoon Hi Cho (BSc (Med) MBBS MIPH FRACP PhD) is a Paediatric Endocrinologist - Staff Specialist at The Children’s Hospital at Westmead and Clinical Associate Professor at the
University of Sydney. She completed a PhD in examining the role of autonomic dysfunction, obesity and puberty in adolescents with type 1 diabetes. Her research interest now extends into pubertal disorders and rare diseases. She leads multicentre
research in hypogonadotropic hypogonadism, collaborates internationally in studies into delayed puberty, and is a principal investigator in clinical trials in Prader Willi Syndrome. She is an APPES and ANZSPED member, currently serving on the ANZSPED Fellows School Committee and Research Grant Review Committee.
Speaker Presentation
Professor Wayne Cutfield
Dr Wayne Cutfield is Professor in Paediatric Endocrinology at the Liggins Institute, University of Auckland and practising paediatric endocrinologist at Starship Children’s Hospital. He single handedly established the paediatric endocrinology service in Auckland which has become a national referral service with outreach clinics provided all around the country. He has trained most of the paediatric endocrinologists and paediatricians with an interest in endocrinology across New Zealand.
He is currently Director of A Better Start National Science Challenge, one of 11 large scale government research initiatives that focuses on the health and well-being of children. Previously he was Director of the Liggins Institute, the University of Auckland’s largest large scale research institute with a focus on the developmental origins of health and disease. He is a former President of the Asia Pacific Paediatric Endocrine Society. He was an elected member of the KIGS Executive Committee and KIGS Scientific Strategy Committee responsible for KIGS research, analyses and publications.
He has published more than 280 peer reviewed manuscripts in leading journals that include the New England Journal of Medicine and the Lancet. He was featured in the perspectives section of the Lancet in 2015.
He is a clinical researcher who leads research teams addressing (i) the role of the microbiome in determining weight gain, metabolism and well-being, (ii) the early prevention of childhood obesity, (iii) growth disorders in childhood and (iv) the early origins of metabolic diseases.
Speaker Presentation
Prof Kim Donaghue
Prof Donaghue remains research active at the University of Sydney, having recently retired from clinical practice at the Children’s Hospital at Westmead (CHW), where she had been Head of the Diabetes Complications Assessment Service, Head of Diabetes Services and CoHead of Endocrinology. She has published over 220 peer reviewed manuscripts and book chapters. Her major research focus has been the pathogenesis of and intervention for diabetes complications. She serves on the Steering Committee for the FAME-1 Eye Trial, an international interventional trial to reduce eye complications.
She currently leads a data linkage project on adult outcomes of childhood-onset diabetes and cosupervises outcomes and data linkage with the Australasian Diabetes Database Network (ADDN) registry. She was awarded the 2015 Australasian Paediatric Endocrine Group (now ANZSPED) Norman Wettenhall Award for Research and Innovation, the 2022 International Society for Pediatric and Adolescent Diabetes (ISPAD) Prize of Achievement and an Australian Diabetes Society Lifetime Achievement Award in 2022.
Dr Donaghue was APEG (now ANZSPED) President 2001-3 serving as Councillor, Treasurer, President and Vice President (1997-2005) and Inaugural Chair of Education Committee (2006-2010). She served on the Royal Australasian College of Physicians Specialty Advisory Committee in Endocrinology. She has given invited lectures for APPES in 1998 and 2010; and invited lectures for the American Diabetes Association, IDF, ESPE, ATTD, ISPE, IMPE. Dr Donaghue was ISPAD President 2018-2020 and led the ISPAD Clinical Practice Consensus Guideline “Vascular complications of diabetes” from 2000 to 2018. She was a recent consultant in diabetes for the World Health Organization and authored the successful submission for WHO EML listing of insulin pen devices in 2023.
In 2025 she was elected to the International Diabetes Federation (IDF) Executive Board as Vice President Strategic Governance. She has 217 Scopus listed papers, and been cited 13,622 times with an H-index of 56.
Speaker Presentation
A/Prof Ronda Greaves
Associate Professor Ronda Greaves is the Deputy Head of Biochemical Genetics at Victorian Clinical Genetics Services (VCGS) and a leading paediatric clinical biochemist. With academic appointments at the University of Melbourne and RMIT, she is a Founding Fellow of the Faculty of Science (RCPA) and currently serves as President of the Australasian Association for Clinical Biochemistry and Laboratory Medicine (AACB).
Ronda played a pivotal role in overseeing the introduction of CAH screening into Victoria’s newborn program. Her expertise in mass spectrometry and steroid profiling is internationally recognised, particularly regarding the unique biochemical challenges of prematurity. This session aims to provide practical insights to
navigate pitfalls and improve diagnostic accuracy of steroid results for preterm neonates.
Speaker Presentation
Prof Olaf Hiort
Professor Olaf Hiort is a full Professor of Paediatrics at the University of Lübeck in Germany. He studied Economics at the University of Hamburg and Human Medicine at the University of Hamburg and at Tufts University of Medicine in Boston, graduating in 1989. He trained in Paediatrics with subspecialities neonatology, paediatric endocrinology and diabetes, as well as laboratory medicine in paediatrics. He obtained his M.D., Ph.D. in 1999 and became Professor in 2001 at the University of Lübeck, currently heading the Division of Paediatric Endocrinology and Diabetes. His scientific focus is on rare endocrine conditions of sex development and calcium and phosphate metabolism. He has coordinated several European projects regarding rare endocrine conditions, namely EuroDSD funded under the 7th EU framework programme and DSDnet, funded as a COST Action under Horizon 2020.
Currently he serves as deputy coordinator and paediatric chair of the European Reference Network for Rare Endocrine Conditions (Endo-ERN). He led the establishment of quality-controlled centres for the care of people with variants of sex characteristics in Germany (DSDCare) and is currently the speaker of the Collaborative Research Centre “sexdiversity - determinants, meanings, and implications of sex diversity in sociocultural, medical and biological landscapes”, funded by the German Research Foundation, which connects 65 scientists mainly from the University of Lübeck dedicated to study the diversity of biological sex.
Speaker Presentation
Dr Takuo Kubota
Takuo Kubota, MD, PhD, is Director of the Department of Nephrology and Metabolism at Osaka Women’s and Children’s Hospital, Japan. He received his medical degree from Osaka University and completed his residency training in general pediatrics and fellowship training in pediatric endocrinology at Osaka University Hospital and affiliated institutions. He subsequently obtained his PhD in Medicine from Osaka University. He is a board-certified Pediatrician and Pediatric Endocrinologist accredited by the Japan Pediatric Society and the Japan Endocrine Society, respectively. He serves as a councilor of the Japan Pediatric Society, the Japan Endocrine Society, the Japanese Society for Pediatric Endocrinology, and the Japanese
Society for Bone and Mineral Research. Through these professional roles, he has been actively involved in academic leadership, education, and the development of clinical practice standards in pediatric metabolic bone diseases and skeletal dysplasias in Japan.
Dr. Kubota’s clinical and research interests focus on pediatric skeletal dysplasias and disorders of bone and mineral metabolism, including achondroplasia, hypochondroplasia, X-linked hypophosphatemic rickets, hypophosphatasia, and osteogenesis imperfecta. His work integrates clinical management, genetic diagnosis, and therapeutic research aimed at improving early diagnosis, disease monitoring, and therapeutic strategies for children with rare bone and mineral disorders. He is actively engaged in national and multicenter collaborative projects and has contributed to the development of Japanese clinical practice guidelines for rare bone and mineral disorders. In addition to his research activities, he is committed to multidisciplinary patient care and collaboration with patient advocacy groups to improve long-term outcomes and quality of life for affected children and their families.
Speaker Presentation
Professor Feihong Luo
Feihong LUO Professor of Pediatrics. Director, Department of Pediatric Endocrinology and Inherited Metabolic Diseases, Children’s Hospital of Fudan University, Shanghai, China. Current social position: Deputy Chairman, Committee of Adolescent Health and Medicine, Chinese Medical Doctor Association; Chair, Group of Endocrinology, Committee of Adolescent Health and Medicine. Deputy chairman，Subspecialty Group of Pediatric Endocrinology, Genetics and Metabolism, Pediatrics Branch, Chinese Medical Association.
Research interests and project funds: Mainly engaged in the diagnosis, clinical
management and basic research of pediatric endocrine and genetic diseases
especially in pediatric diabetes. Research projects are mainly supported by the
National Key Research and Development Program of China, National Natural
Science Foundation of China.
Speaker Presentation
Ms Angie Manzke
Angie is an Accredited Mental Health Social Worker and Psychotherapist and is the founder of Reflective Haven. Reflective Haven is an online National Type 1 Diabetes Counselling Service dedicated to supporting parents, youth and adults.
She has 22 years’ experience in counselling, group work and teaching. She offers a unique approach using alternative therapies such as art therapy, Clayfield therapy, EMDR, psychodynamic therapy and somatic therapies. She has supported thousands of families with type 1 diabetes of all ages and is passionate about reducing anxiety and increasing communication in families to support their child with diabetes using a trauma-informed approach.
Speaker Presentation
Asst/Prof Supitcha Patjamontri
Asst Prof. Supitcha Patjamontri is an Assistant Professor in the Division of Endocrinology and Metabolism, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. He completed his medical degree at Siriraj Hospital and is board certified in Pediatrics and Pediatric Endocrinology by the Medical Council of Thailand. Dr Patjamontri undertook a Clinical Research Fellowship in Paediatric Endocrinology at the University of Glasgow and the Royal Hospital for Children, Glasgow, UK.
His clinical and academic work focuses on disorders of sex development, pubertal disorders, adrenal conditions, and congenital hyperinsulinism. He is actively involved in fellowship training, research, and national committees within the Thai Society for Pediatric Endocrinology and has published extensively in leading international journals.
Speaker Presentation
Prof Aman Pulungman
Aman Pulungan is a professor of pediatrics in Faculty of Medicine, University of Indonesia, immediate past Executive Director of the International Paediatric Association, senior consultant in pediatric endocrinology, member of the NCD Child Governing Council, past president of the Asia Pacific Pediatric Association, past president of the Indonesian Pediatric Society, and past president of the Asia Pacific Pediatric Endocrine Society (APPES). For the past 30 years, he has been involved in many programs for diabetes in Indonesia and the Asia Pacific region. Amongst others, he is the project leader of the World Diabetes Foundation Type 1 DM in Indonesia and the project leader of Changing Diabetes in Children (CDiC) in Indonesia. As a clinician and researcher, he has published more than 100 scientific articles in various international journals and book chapters, as well as popular articles.
The Indonesian MOH awarded him as one of the most eminent people actively involved in the national immunization program. He has received an honorary fellowship from the Turkish National Paediatric Association for his dedication and contribution to child health, an honorary fellowship from the Royal College of Physicians of Ireland (RCPI), and an honorary fellowship from the Indian Academy of Paediatrics (IAP). He also received the Republika.co.id Inspirational Figure Award in 2021 for his contributions during the COVID-19 pandemic and a Lifetime Achievement Alumni Award from the University of North Sumatera (USU) in 2023. Furthermore, he also received the Advocacy and Lifetime Achievement in Pediatrics Award 2024 from European Pediatric Association, Union of National European Pediatric Societies and Associations (EPA/UNEPSA).
Speaker Presentation
Prof Rodolfo Rey
Rodolfo Rey is a Medical Doctor from the National University of Rosario and obtained a PhD from the University of Buenos Aires, Argentina, and a Master's degree in Endocrinology and Cell Interactions from the University of Paris XI, France. He is a specialist in Genetics (Argentine Society of Genetics) and Andrology (Argentine Society of Andrology), and trained in Paediatrics and Paediatric Endocrinology at the Ricardo Gutiérrez Children's Hospital in Buenos Aires. Dr Rey trained as a postdoctoral fellow in Paris, at the INSERM Unit directed by Dr Nathalie Josso, working on the physiology and genetics of anti-Müllerian hormone (AMH). Since 1998, he has been a Researcher of CONICET (National Research Council of Argentina), currently a Senior Researcher and Director of CEDIE (Centre for Endocrinological Research), Buenos Aires Children’s Hospital. He is also Professor of Histology, Embryology, Cell Biology, and Genetics at the Faculty of Medicine of the University of Buenos Aires.
Throughout his career as a researcher in the area of experimental and clinically applied Endocrinology, his translational approach has been a defining characteristic. Questions arising from human observations regarding the morphological and functional changes of the hypothalamic-pituitary-gonadal axis formed the basis for observational studies in humans and experimental studies in primate and rodent models. He was part of the group that developed and patented in Europe the first assay for determining AMH in bodily fluids, now commercially available worldwide. Using AMH as a biomarker, he has led a group that characterised numerous cases of hypogonadism from fetal life to puberty.
SLEP Sponsored Speaker
Speaker Presentation
Ms Debra Sadie
Deb Sadie has worked at The Children’s Hospital at Westmead (CHW) since 2012 as a Diabetes Clinical Nurse Consultant, CDE .
Deb also works as a private CDE with adults one day per week and thus has broad experience working with people living with type 1 diabetes across both the adult and paediatric population.
Deb has a special interest in diabetes technologies and enjoys helping people living with diabetes to achieve optimal health outcomes and live well with diabetes.
Speaker Presentation
Dr Vinutha Shetty
Dr Vinutha Shetty is a Consultant Endocrinologist at Perth Children’s Hospital, Clinical Lecturer at the University of Western Australia, and Honorary Research Associate with the Kids Research Institute. She leads the Adolescent Diabetes Service and is nationally recognised for her work in exercise and Type
1 diabetes. Her PhD research has shaped international guidelines for exercise in youth with diabetes and informed the co-development of the acT1ve app for young people. Dr
Shetty’s work spans transitional care, nutrition, mental health, and digital interventions. She is currently developing a Transitional Diabetes Care Clinic for young people aged 16–25 and leads innovative projects such as Teaching Kitchens to support self-care, resilience, and behavioural change in adolescents with T1D. A strong advocate for health equity, integrative care, and environmental sustainability, she brings a bold, collaborative, and
values-driven approach to her clinical and academic leadership.
Speaker Presentation
A/Prof Peter Simm
A/Prof Peter Simm is a Paediatric Endocrinologist from the
Royal Children’s Hospital, Melbourne, Australia. He has clinical and research interests in Bone and Mineral medicine, having founded the bone health clinic at RCH as well as leading the clinical densitometry service. Peter is a former Chair of the Australia and New Zealand Society for Paediatric Endocrinology and Diabetes (ANZSPED, formerly APEG)’s Bone and mineral working group, as well as former ANZSPED president.
He is a member of the International Society for Children's Bone Health (ISCBH) steering committee and also a member of the ISCBH POC. He is also a member of the Australia and New Zealand Bone and Mineral Society (ANZBMS) therapeutics committee, Peter’s research interests include the effect of epilepsy and its therapies on the developing skeleton, X linked hypophosphatemia, population assessments of bone health, management of osteogenesis imperfecta especially around transition and the negative sequelae of spinal cord injury on lower limb bone strength.
Human Growth Foundation Sponsored Speaker
Speaker Presentation
Dr Denise Steers
Denise completed her PhD (2020) which explored the decision making process for infants born Innate intersex/variations in sex characteristics (IVSC/DSD) in Aotearoa/New Zealand. Denise is currently researcher at the University of Otago working on developing resources for children/young people and their families. Denise has a clinical psychology background in child, adolescent and family mental health. Her research
interests are focused on the complexity of sex, gender and sex characteristics, and the lived experience of people marginalised in society from a human rights and psychosocial perspective.
Denise is involved in continued building of relationships between those with lived experience and healthcare providers to pathways for collaboration in achieving shared positive outcomes that adhere to rights based practice. This is especially important in a world where there is a trend toward returning to outdated points of view around gender and a lack of rights based perspectives that honour and value the perspectives of those with lived experience.
Speaker Presentation
Prof Toshihiro Tajima
Professor Toshihiro Tajima, MD is Professor of Pediatrics at Jichi Medical University, Japan. He received his medical degree from Hokkaido University School of Medicine and has extensive expertise in pediatric endocrinology. Professor Tajima has held academic appointments at Hokkaido University Graduate School of Medicine and completed international research training as a Research Fellow at the National Institute of Child Health and Human Development, National Institutes of Health (USA).
He has been widely recognised for his contributions to the field, receiving multiple awards from the Japanese Society for Pediatric Endocrinology and The Japan Endocrine Society, including the Society Award in 2024. Professor Tajima currently serves as President of the Japanese Society for Pediatric Endocrinology and holds leadership roles within several national and international endocrine organisations.
Speaker Presentation
Dr Joanna Yuet-Ling Tung
Dr. Joanna Yuet-ling Tung is a Paediatric Endocrinologist with a special interest in paediatric bone diseases. She is the Service Head of Paediatric Endocrinology at Hong Kong Children’s Hospital. Dr. Tung also serves as an Honorary Associate Professor at the University of Hong Kong. Her clinical and research work focuses on advancing paediatric endocrinology and bone health through multidisciplinary care and innovation. Dr. Tung actively contributes to professional organizations regionally and internationally. She is a Council Member of the Asia Pacific Paediatric Endocrine Society (APPES), President of the Hong Kong Society of Paediatric Endocrinology and Metabolism (HKSPEM), and Co-chair of the Emerging Investigators Group of the International Society for Children’s Bone Health (ISCBH). She also served on the Organizing Committee for the International Osteogenesis Imperfecta Conference 2025.
Human Growth Foundation Sponsored Speaker
Speaker Presentation
A/Prof Albert Wiegman
Albert Wiegman, Amsterdam, became a paediatrician and member of the staff at the Amsterdam University Medical Centres in 1991. In 1993, he completed his sub-specialization in paediatric cardiology, and the Paediatric-Lipid Department came under his care. He started the detection and treatment of children with homozygous and heterozygous familial hypercholesterolemia and other dyslipidaemias in the Netherlands. In 2020, he was appointed Associate Professor and Principal Investigator.
In 30 years, over 4000 children with inherited dyslipidaemias visited his ward. He co-authored more than 150 peer-reviewed papers in this field. Since 2024, he is an appointed trustee of the Familial Hyperlipidaemia Europe Foundation and a core group member of the Lipoprotein(a) International Taskforce.
Speaker Presentation
Dr Jinhua Yan
Dr Jinhua Yan is a Chief Physician in the Department of Endocrinology, Doctoral Supervisor, and Head of the Diabetes Subspecialty at the Third Affiliated Hospital of Sun Yat-sen University. She is an active member of the Type 1 Diabetes Group of the Chinese Diabetes Society and the Endocrinology Branch of the Guangdong Medical Association.
Dr Yan’s research focuses on type 1 diabetes mellitus and type 2 diabetes mellitus complicated by non-alcoholic fatty liver disease (NAFLD). Her work has been supported by major national and provincial research grants, including funding from the National Natural Science Foundation of China. She has published extensively as first or corresponding author in leading international journals and was the recipient of the 11th Guangzhou Good Doctor Award in 2025, as well as multiple Chinese Medical Science and Technology Awards.
Speaker Presentation
